Exploring the Link between Xanthine Oxidase Inhibitors and Risk of Heart Failure: Clinical Validation and Potential Molecular Mechanisms

Project title

探索黃嘌呤氧化酶抑制劑與心衰竭風險之關聯性：臨床驗證及潛在分子機制

Internal ID

MOST110-2320-B002-027

Principal Investigator

Start Date

August 1, 2021

End Date

July 31, 2022

Investigators

Organizations

Clinical Pharmacy

Partner Organizations

National Science and Technology Council